Novozymes Company Profile

Aggregated data from the web about Novozymes

Company Name	Novozymes
Website	https://www.novozymes.com
Snippet	The Novozymes Report 2022. Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and Novozymes is confident about the 2023 outlook of 4-7%. Global challenges are queuing up.
ISIN	DK0010272129
Type	Aktieselskab
Parent	Novo A/S
Founded	2000
Revenue	DKK 14,374 million(2019)[1]
Website	www.novozymes.com
Industry	Biotechnology
Products	Enzymes, microorganisms, biopharmaceutical ingredients
Traded as	Nasdaq Copenhagen: NZYM B
Key people	Jørgen Buhl Rasmussen (Chairman), Ester Baiget (President and CEO)
Net income	DKK 3,155 million (2019)[1]
Headquarters	Bagsværd, Denmark
Total assets	18,659,000,000 Danish krone[2] (31 December 2016)
Operating income	DKK 4,039 million(2019)[1]
Number of employees	6,125 (2019)[1]

Novozymes is part of the Denmark company list

Novozymes is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.